Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year Low – Should You Sell?

Prestige Consumer Healthcare Inc. (NYSE:PBH) shares reached a new 52-week low during trading on Monday . The company traded as low as $50.74 and last traded at $51.1850, with a volume of 17564 shares changing hands. The stock had previously closed at $54.59.

Analysts Set New Price Targets

A number of research firms recently commented on PBH. Jefferies Financial Group decreased their price objective on Prestige Consumer Healthcare from $70.00 to $66.00 and set a “hold” rating on the stock in a report on Friday, January 30th. Weiss Ratings reiterated a “hold (c)” rating on shares of Prestige Consumer Healthcare in a report on Tuesday, April 21st. Finally, Oppenheimer decreased their price objective on Prestige Consumer Healthcare from $77.00 to $65.00 and set an “outperform” rating on the stock in a report on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $74.75.

Prestige Consumer Healthcare Trading Down 0.2%

The company has a market cap of $2.39 billion, a PE ratio of 13.37, a price-to-earnings-growth ratio of 1.52 and a beta of 0.40. The company has a quick ratio of 1.93, a current ratio of 3.11 and a debt-to-equity ratio of 0.58. The business has a 50-day simple moving average of $59.12 and a 200-day simple moving average of $61.68.

Insider Transactions at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, VP Jeffrey Zerillo sold 1,207 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $54.99, for a total value of $66,372.93. Following the sale, the vice president owned 42,820 shares of the company’s stock, valued at $2,354,671.80. The trade was a 2.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.40% of the stock is currently owned by insiders.

Institutional Trading of Prestige Consumer Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. raised its position in Prestige Consumer Healthcare by 24.8% in the first quarter. PNC Financial Services Group Inc. now owns 7,740 shares of the company’s stock valued at $459,000 after purchasing an additional 1,539 shares during the period. Dimensional Fund Advisors LP raised its position in Prestige Consumer Healthcare by 3.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,672,777 shares of the company’s stock valued at $158,414,000 after purchasing an additional 91,710 shares during the period. KBC Group NV raised its position in Prestige Consumer Healthcare by 38.9% in the first quarter. KBC Group NV now owns 1,992 shares of the company’s stock valued at $118,000 after purchasing an additional 558 shares during the period. Heartland Advisors Inc. raised its position in Prestige Consumer Healthcare by 6.6% in the first quarter. Heartland Advisors Inc. now owns 79,921 shares of the company’s stock valued at $4,737,000 after purchasing an additional 4,930 shares during the period. Finally, Cornerstone Planning Group LLC purchased a new stake in Prestige Consumer Healthcare in the first quarter valued at approximately $44,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).